Cem Erdogan

Dr. Cem Erdogan


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2025 in Acta Physiologica
Verified
Journal Article
Open access
LZLiang Zhao
Liang Zhao
MXMinze Xu
Minze Xu
APAnna Maria Pfefferkorn
Anna Maria Pfefferkorn
CECem Erdogan
Cem Erdogan
HSHubert Schwelberger
Hubert Schwelberger
MAMuhammad Imtiaz Ashraf
Muhammad Imtiaz Ashraf
Aim: Dilatory microvascular function is impaired in ischemia/reperfusion injury in the kidney. Nitric oxide independent activators of soluble guanylyl cyclase (sGC) provide renal protection by dilating microvessels and preserving perfusion, but their efficacy declines after severe hypoxia. This study explores whether lipocalin‐2 (Lcn2), a key iron‐transporting protein, can restore the sGC‐mediated dilation in mouse afferent arterioles (AAs) after hypoxia/reoxygenation (H/R) and kidney transplantation.Methods: Dilation of isolated, angiotensin II (Ang II) pre‐constricted, AAs was induced by application of sGC activator cinaciguat after pre‐constriction with Ang II following H/R (H: 30 min, R: 10 min ± holo‐rLcn2, apo‐rLcn2, deferoxamine) and syngeneic kidney transplantation (cold ischemia: 30 min or 5.5 h, reperfusion: 20 h ± holo‐rLcn2) in C57BL/6 mice. To corroborate the dilatory function at the organ level, vascular relaxation was assessed using an isolated mouse kidney perfusion system.Results: Dilation of AAs was impaired following H/R. Pretreatment with holo‐rLcn2 (iron‐bound) preserved dilation, whereas apo‐rLcn2 (iron‐free) had no effect. The reversal of holo‐rLcn2's effect by deferoxamine confirmed the role of iron. AAs from kidney transplants showed reduced dilation compared to sham‐operated controls, with greater impairment following prolonged ischemia. Treatment with holo‐rLcn2 significantly improved dilatory function after extended cold ischemia (5.5 h), restoring it to levels seen with shorter ischemia (30 min). Ex vivo perfusion of the isolated mouse kidney with holo‐rLcn2 enhanced cinaciguat‐induced vascular relaxation, confirming its beneficial effect at the organ level.Conclusion: This study identifies a novel role for holo‐rLcn2 in preserving renal vascular function post‐H/R and kidney transplantation, apparently by upholding iron levels in vascular cells.

Verified
Journal Article
Open access
PDF file
CZCHENG ZHONG
CHENG ZHONG
MXMinze Xu
Minze Xu
SBSengül Boral
Sengül Boral
HSHolger Summer
Holger Summer
FLFalk Bach Lichtenberger
Falk Bach Lichtenberger
PKPratik Hemant Khedkar
Pratik Hemant Khedkar
Endothelial dysfunction (ED) comes with age, even without overt vessel damage such as that which occurs in atherosclerosis and diabetic vasculopathy. We hypothesized that aging would affect the downstream signalling of the endothelial nitric oxide (NO) system in the vascular smooth muscle (VSM). With this in mind, resistance mesenteric arteries were isolated from 13-week (juvenile) and 40-week-old (aged) mice and tested under isometric conditions using wire myography. Acetylcholine (ACh)-induced relaxation was reduced in aged as compared to juvenile vessels. Pretreatment with L-NAME, which inhibits nitrix oxide synthases (NOS), decreased ACh-mediated vasorelaxation, whereby differences in vasorelaxation between groups disappeared. Endothelium-independent vasorelaxation by the NO donor sodium nitroprusside (SNP) was similar in both groups; however, SNP bolus application (10−6 mol L−1) as well as soluble guanylyl cyclase (sGC) activation by runcaciguat (10−6 mol L−1) caused faster responses in juvenile vessels. This was accompanied by higher cGMP concentrations and a stronger response to the PDE5 inhibitor sildenafil in juvenile vessels. Mesenteric arteries and aortas did not reveal apparent histological differences between groups (van Gieson staining). The mRNA expression of the α1 and α2 subunits of sGC was lower in aged animals, as was PDE5 mRNA expression. In conclusion, vasorelaxation is compromised at an early age in mice even in the absence of histopathological alterations. Vascular smooth muscle sGC is a key element in aged vessel dysfunction.

Verified
Journal Article
Open access
PDF file
MXMinze Xu
Minze Xu
FLFalk Bach Lichtenberger
Falk Bach Lichtenberger
CECem Erdoǧan
Cem Erdoǧan
ELEn Yin Lai
En Yin Lai
PPPontus B. Persson
Pontus B. Persson
PKPratik Hemant Khedkar
Pratik Hemant Khedkar
Reduced renal medullary oxygen supply is a key factor in the pathogenesis of acute kidney injury (AKI). As the medulla exclusively receives blood through descending vasa recta (DVR), dilating these microvessels after AKI may help in renoprotection by restoring renal medullary blood flow. We stimulated the NO-sGC-cGMP signalling pathway in DVR at three different levels before and after hypoxia/re-oxygenation (H/R). Rat DVR were isolated and perfused under isobaric conditions. The phosphodiesterase 5 (PDE5) inhibitor sildenafil (10−6 mol/L) impaired cGMP degradation and dilated DVR pre-constricted with angiotensin II (Ang II, 10−6 mol/L). Dilations by the soluble guanylyl cyclase (sGC) activator BAY 60-2770 as well as the nitric oxide donor sodium nitroprusside (SNP, 10−3 mol/L) were equally effective. Hypoxia (0.1% O2) augmented DVR constriction by Ang II, thus potentially aggravating tissue hypoxia. H/R left DVR unresponsive to sildenafil, yet sGC activation by BAY 60-2770 effectively dilated DVR. Dilation to SNP under H/R is delayed. In conclusion, H/R renders PDE5 inhibition ineffective in dilating the crucial vessels supplying the area at risk for hypoxic damage. Stimulating sGC appears to be the most effective in restoring renal medullary blood flow after H/R and may prove to be the best target for maintaining oxygenation to this vulnerable area of the kidney.


17 December 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
AGAliihsan Gemi̇cİ
Aliihsan Gemi̇cİ
HBHülya Bi̇lGen
Hülya Bi̇lGen
CECem Erdogan
Cem Erdogan
AKAbdullah Kansu
Abdullah Kansu
OOOktay Olmuşçeli̇k
Oktay Olmuşçeli̇k
OSOmur Gokmen Sevindik
Omur Gokmen Sevindik
Background/aim: A SARS-Cov2 infection which was first arised from Wuhan in December 2019 and named as COVID-19. Still there lacks either a specific treatment or a vaccine to treat COVID-19. Convalescent plasma (CP) was previously used successfully to treat SARS-CoV-1 and MERS infections. Health authority in Turkey has published a guideline to integrate this promising option in the treatment process of patients who are prone to high risk of developing severe COVID-19. Materials and Methods: Forty consecutive patients who had received CP at our center were included in the study. Demographics, COVID-19 specific parameters, biomarkers to detect the severity of COVID-19 infection and outcome variables were collected retrospectively. The correlation between outcome variables and the independent predictors of the outcome were reported. Results: Median age of the patients was 57.5 and 72.5% were male. At least one COVID-19 PCR test was confirmed to be positive in 75% of patients. Remaining 25% had a Chest-CT which was reported to be compatible with an ongoing COVID-19. All patients (100%) were classified as having severe COVID-19 infection. Over a half of the patients harbored an oxygen saturation of less than 90 despite of a continuous 5 L/min support of O-2. 82.5% of the patients had a need for mechanical ventilation and 45.5% had a need for invasive mechanical ventilation. Nine out of 10 patients who have received CP outside ICU have totally recovered from COVID-19 at a median of 9 days, and a half of the patients who needed invasive mechanical ventilation were successfully free of mechanical ventilation support and managed to recover from COVID-19. Conclusion: According to the results of this study, CP is an efficient conjunct to conventional therapy against COVID-19 with a favorable safety profile.

5 August 2020 in Ain-Shams Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
CECem Erdogan
Cem Erdogan
SDSibel Doğan
Sibel Doğan
RÇRumeysa Çakmak
Rumeysa Çakmak
DKDeniz Kizilaslan
Deniz Kizilaslan
BHBurcu Hizarci
Burcu Hizarci
HÖHüseyin Öz
Hüseyin Öz
Objective: We aimed to evaluate whether working at ICU, inpatient services, or the operating room creates differences in job satisfaction (JS), work-related strain (WRS), and perceived stress (PS) of nurses.Research methodology: The study data were collected through face-to-face interviews. The data collection tools utilized in the study included a questionnaire form consisting of 19 questions.Work-Related Strain Inventory (WRSI), Short-Form Minnesota Job Satisfaction Questionnaire (SF-MSQ), and the Perceived Stress Scale (PSS) were used.Results: Across all groups, the mean scores of SF-MSQ were statistically significantly the lowest in the groups of nurses, who were not economically satisfied with their salaries at all, who reported that they did not do their dream jobs and that they were not fond of their jobs.The mean scores of WRSI were statistically significantly the lowest across all groups in the groups of nurses.The mean PSS scores were statistically significantly the lowest across all compared groups in the groups of nurses, who commute to work by their private cars.Conclusion: Hospital management and nursing services should address the overtime working conditions of nurses and provide satisfactory wage improvements.